Symbol | Exchange | Currency |
|---|
March 31 (Reuters) - Glaxo Smithkline Consumer Nigeria PLC GLAXOSM.LG : * GLAXO SMITHKLINE CONSUMER NIGERIA PLC - FY GROUP REVENUE 21.30 BILLIONNAIRAVERSUS 20.76 BILLION NAIRA *...
Oct 23 (Reuters) - Glaxo Smithkline Consumer Nigeria PLC GLAXOSM.LG : * GLAXO SMITHKLINE CONSUMER NIGERIA PLC - QTRLY GROUP PRETAXPROFIT 61.8 MILLION NAIRA VERSUS 81.5 MILLION...
(Adds details) By Chijioke Ohuocha ABUJA, Oct 5 (Reuters) - Nigerian stocks rose to theirhighest in more than seven months on Monday after 11 straightdays of gains as excess...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Buy | Buy | Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.75 | 1.75 | 1.73 | +0.020 | +1.16% | 870.80K | Lagos | |||
| 0.20 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 0.20 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 0.79 | 0.00 | 0.00 | +0.03 | +3.95% | 8.40M | Lagos | |||
| 7.30 | 7.30 | 7.30 | -0.70 | -8.75% | 19.51K | Lagos | |||
| 0.50 | 0.00 | 0.00 | +0.03 | +6.38% | 591.11K | Lagos | |||
| 1.15 | 1.15 | 1.15 | +0.100 | +9.52% | 213.90K | Lagos | |||
| 0.60 | 0.00 | 0.00 | +0.02 | +3.45% | 4.44M | Lagos | |||
| 1.24 | 1.24 | 1.24 | 0.00 | 0.00% | 2.50K | Lagos | |||
| 5.90 | 5.90 | 5.90 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 0.20 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 0.50 | 0.00 | 0.00 | +0.02 | +4.35% | 621.40K | Lagos | |||
| 6.50 | 6.50 | 6.50 | -0.70 | -9.72% | 12.01K | Lagos | |||
| 5.20 | 5.20 | 5.20 | +0.200 | +4.00% | 103.09K | Lagos | |||
| 2.30 | 2.30 | 2.30 | 0.000 | 0.00% | 1.69M | Lagos |
GlaxoSmithKline Consumer Nigeria Plc is a Nigeria-based research-based pharmaceutical and healthcare company. The principal activities of the Company are manufacturing, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's operating segments include Pharmaceuticals and Consumer Healthcare. The Consumer Healthcare segment includes oral care, over-the-counter (OTC) medicines and nutritional healthcare. The Pharmaceuticals segment consists of antibacteria, vaccines and prescription drugs. The Company offers Consumer Healthcare brands, such as Panadol, Andrews Liver Salt, Macleans, Otrivin, Sensodyne, Voltaren and a range of pharmaceuticals, including Ampiclox, Amoxil, Augmentin, Zentel, Halfan and vaccines. Global Manufacturing and Supply (GMS) is the manufacturing unit of the Company located in Agbara, Ogun State.